![Mirum Pharmaceuticals, Inc. logo](/logos/MIRM.webp)
Mirum Pharmaceuticals, Inc.
NASDAQ:MIRM
Overview | Financials
Company Name | Mirum Pharmaceuticals, Inc. |
Symbol | MIRM |
Currency | USD |
Price | 41.12 |
Market Cap | 1,961,720,064 |
Dividend Yield | 0% |
52-week-range | 23.14 - 45.23 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Christopher Peetz |
Website | https://www.mirumpharma.com |
An error occurred while fetching data.
About Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD